Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites;
Rasagiline, is a selective and irreversible propargylamine inhibitor of monoamine oxidase which has been used to increase the availability of dopamine at striatal receptors as a method to treat ParkinsonтАЩs disease.